These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy. Janknegt R Pharm Weekbl Sci; 1986 Feb; 8(1):1-21. PubMed ID: 3515312 [TBL] [Abstract][Full Text] [Related]
3. The possible role of quinolones in yersiniosis. Hoogkamp-Korstanje JA Drugs; 1987; 34 Suppl 1():134-8. PubMed ID: 3436262 [TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin concentrations in tonsils following single or multiple administrations. Falser N; Dalhoff A; Weuta H Infection; 1988; 16 Suppl 1():S14-8. PubMed ID: 3372028 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic bacterial prostatitis with ciprofloxacin. Langemeyer TN; Ferwerda WH; Hoogkamp-Korstanje JA; de Leur EJ; van Oort H; Schipper JJ; van der Wal T Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S78-81. PubMed ID: 3325933 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Neuman M Clin Pharmacokinet; 1988 Feb; 14(2):96-121. PubMed ID: 3282749 [TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of ciprofloxacin following oral and intravenous administration. Dalhoff A; Eickenberg HU Infection; 1985; 13(2):78-81. PubMed ID: 3158611 [TBL] [Abstract][Full Text] [Related]
8. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Gasser TC; Graversen PH; Madsen PO Antimicrob Agents Chemother; 1987 Jul; 31(7):1010-3. PubMed ID: 3116916 [TBL] [Abstract][Full Text] [Related]
9. Concentration of ciprofloxacin in human prostatic tissue after oral administration. Dan M; Golomb J; Gorea A; Braf Z; Berger SA Antimicrob Agents Chemother; 1986 Jul; 30(1):88-9. PubMed ID: 2944481 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. Arya OP; Hobson D; Hart CA; Bartzokas C; Pratt BC Genitourin Med; 1986 Jun; 62(3):170-4. PubMed ID: 2942454 [TBL] [Abstract][Full Text] [Related]
11. Single and multiple dose pharmacokinetics of ciprofloxacin. Ullmann U; Giebel W; Dalhoff A; Koeppe P Eur J Clin Microbiol; 1986 Apr; 5(2):193-6. PubMed ID: 2941279 [TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography. Groeneveld AJ; Brouwers JR Pharm Weekbl Sci; 1986 Feb; 8(1):79-84. PubMed ID: 2938073 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin pharmacokinetics in patients with cystic fibrosis. Bender SW; Dalhoff A; Shah PM; Strehl R; Posselt HG Infection; 1986; 14(1):17-21. PubMed ID: 2937737 [TBL] [Abstract][Full Text] [Related]
14. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Hooper DC; Wolfson JS Antimicrob Agents Chemother; 1985 Nov; 28(5):716-21. PubMed ID: 2936302 [No Abstract] [Full Text] [Related]
16. Use of quinolones in treatment of prostatitis and lower urinary tract infections. Andriole VT Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):342-50. PubMed ID: 1864295 [TBL] [Abstract][Full Text] [Related]
17. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens. Hoogkamp-Korstanje JA; van Oort HJ; Schipper JJ; van der Wal T J Antimicrob Chemother; 1984 Dec; 14(6):641-5. PubMed ID: 6440885 [TBL] [Abstract][Full Text] [Related]